Latest for Aplastic Anemia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line… (Phase 2)ClinicalTrials.gov
- Who can joinWho can join changed for Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic… (Phase 2)ClinicalTrials.gov
More about Aplastic Anemia
Aplastic anemia (AA) is a rare acquired or inherited bone marrow failure syndrome characterized by peripheral pancytopenia (anemia, thrombocytopenia, neutropenia) with hypocellular bone marrow and reduced hematopoietic precursors.
Keep reading about Aplastic Anemia
Pathophysiology involves loss of hematopoietic stem cell and progenitor cell populations from multiple potential mechanisms: immune-mediated destruction (~50% of acquired cases via autoreactive T-cell cytotoxicity), direct toxic injury to stem cells (drug-induced from chemotherapy, antibiotics like chloramphenicol), viral infections (especially hepatitis-associated aplastic anemia), radiation exposure, chemical exposures (benzene), or genetic predisposition in inherited forms (Fanconi anemia, dyskeratosis congenita).
The condition manifests with symptoms of anemia (fatigue, dyspnea, exercise intolerance), bleeding from thrombocytopenia (petechiae, mucosal bleeding, intracranial hemorrhage), and infections from neutropenia including fever and opportunistic infections. Diagnosis requires bone marrow examination showing hypocellularity (<25% cellularity) with reduced hematopoietic precursors. Severity is classified as non-severe, severe, or very severe based on neutrophil, platelet, and reticulocyte counts. Untreated severe aplastic anemia carries poor prognosis with high mortality from infections and hemorrhage.
What are the symptoms of Aplastic Anemia?
These are common symptoms of Aplastic Anemia, and how strong they are varies from person to person.
- Fatigue and dyspnea from anemia
- Petechiae and bleeding from thrombocytopenia
- Infections from neutropenia
- Fever without obvious source
- Splenomegaly occasionally present
- Macrocytic anemia on blood smear
Who gets Aplastic Anemia?
Can present at any age with bimodal distribution showing peaks at 20-25 years and 60+ years. Equal gender distribution overall. Can be idiopathic or secondary to drug exposures, radiation, or infections. Higher incidence in Asian populations compared to Western countries.
Increased risk with chemotherapy exposure, radiation therapy, immunosuppressive treatments, and certain infections. No clear ethnic predisposition for immune-mediated forms. Exposure history and temporal relationship to presumed trigger important for classification.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Aplastic Anemia?
There are currently 4 FDA-approved medications for Aplastic Anemia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Aplastic Anemia treatment
Charity funds and drugmaker programs for Aplastic Anemia, checked at the source.
- Alvaiz (Eltrombopag choline) · Alvaiz Savings Program
- Promacta (Eltrombopag) · Novartis Patient Support / Universal Co-pay Program
- Neoral (Cyclosporine) · Generic from many makers
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Aplastic Anemia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Aplastic Anemia resources
Reputable organizations and medical references for learning more about Aplastic Anemia, including disease registries, foundation resources, and clinical guidelines.